[1] Bopanna S, Ananthakrishnan AN, Kedia S, et al.Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2017, 2(4): 269-276. [2] Wang YN, Li J, Zheng WY, et al.Clinical characteristics of ulcerative colitis-related colorectal cancer in Chinese patients[J]. J Dig Dis, 2017, 18(12): 684-690. [3] 屠明华. 从《伤寒论》辨证分析溃疡性结肠炎的发病机理及治疗方药[J]. 四川中医,2020,38(8):33-36. [4] 朱巧玲,张荣珍,谢强龙. 清肠解毒方对肠癌患者胃肠道功能、生存质量的影响[J]. 四川中医,2021,39(6):92-95. [5] 马秀兰,王秀萍,王佳林,等. 大鼠溃疡性结肠炎模型的建立[J]. 中医药临床杂志,2021,33(9):1754-1759. [6] Riddell RH, Goldman H, Ransohoff DF, et al.Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications[J]. Hum Pathol, 1983, 14(11): 931-968. [7] Pekow J, Meckel K, Dougherty U, et al.miR-193a-3p is a Key tumor suppressor in ulcerative colitis-associated colon cancer and promotes carcinogenesis through upregulation of IL17RD[J]. Clin Cancer Res, 2017, 23(17): 5281-5291. [8] Guan H, Piao H, Qian Z, et al.2,5-Hexanedione induces autophagic death of VSC4.1 cells via a PI3K/Akt/mTOR pathway[J]. Mol Biosyst, 2017, 13(10): 1993-2005. [9] Wang X, Li D, Zhang Y,et al.Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway[J]. Exp Ther Med, 2018, 15(5): 4477-4484. [10] 符顺丹,吴胜. 自拟疏风清热解毒汤辅助治疗小儿急性上呼吸道感染(表里俱热证)疗效观察[J]. 四川中医,2022,40(5):82-85. [11] 管政,王也,王长振,等. 栀子醇提物对食源性微生物抑制效果的研究[J]. 中华微生物学和免疫学杂志,2018,38(11):871-875. [12] 梁英,金迪,李丹丹,等. 黄芩多糖的免疫调节活性[J]. 中国食品学报,2017,17(2):23-27. [13] 左诗淳,李慧杰. 齐元富巧用枳壳白术治疗胃癌经验[J]. 山东中医杂志,2017,36(4):313-314,321. [14] Yu JS, Cui W.Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination[J]. Development, 2016, 143(17): 3050-3060. [15] Wu XL, Wang LK, Yang DD, et al.Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway[J]. J Cell Biochem, 2018, 119(2): 2356-2367. |